 mmol/L (40 mg/dL) are suggested as target in ESC-EAS guidelines.19 With statin
therapy such as rosuvastatin 20 e 40 mg or atorvastatin
40 e 80 mg, marked reductions of LDL cholesterol can
be achieved if these relatively simple treatments are
tolerated. When the target is not reached ezetimibe can
be added, which is available in combination tablets with
both